Funding available for basic research on biological/genetic causes of cancer health disparities to support innovative studies and enhance expertise in the field.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing date)
Funding Amounts: No budget limit; requests must reflect project needs; maximum project period of 5 years; no cost sharing required
Summary: Supports basic, mechanistic research into biological and genetic contributors to cancer health disparities.
Key Information: Clinical trials are not allowed; projects must mechanistically connect race/ethnicity and/or other social determinants with cancer biology.
The National Cancer Institute (NCI), part of NIH, supports R01 research projects investigating biological and genetic contributors to cancer health disparities. The program funds mechanistic studies in cancer biology and prevention, development and testing of methodologies and models, and secondary data analyses. Its goals include identifying cancer risks and risk-reduction strategies, understanding factors that cause cancer, and developing mechanisms for cancer prevention.
The program also seeks to grow a nationwide cohort of scientists with expertise in basic cancer health disparities research and expand resources such as biospecimens, patient-derived models, and research methods. Research areas include early detection and prevention, cancer initiation and progression, symptom management during cancer and treatment, and technology development. Immediate clinical translational potential is not required.